NCT04390100

Brief Summary

Free gingival graft (FGG) was first proposed by Bjorn 1963 and Nabers 1966. FGG is indicated to correct mucogingival problems such as inadequate or lack of attached gingiva and gingival recession. The most frequent donor site for free gingival graft is the palate Although, great concern has been given to the recipient sites by using different techniques as suturing, tissue adhesives and special dressings, a little attention was given to protect the donor sites after free gingival graft harvesting. The palatal donor site heal by secondary intention, it could take around 2 to 4 weeks depending on the width and thickness of the tissue removed.The common clinical events that occurs following FGG procedure are patient's discomfort, pain and bleeding at the donor site.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Feb 2019

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 9, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 15, 2020

Completed
Last Updated

May 15, 2020

Status Verified

May 1, 2020

Enrollment Period

10 months

First QC Date

May 9, 2020

Last Update Submit

May 13, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • visual analogue scale(VAS)

    evaluate of the pain at 3,7,14,21 and 30 with score staring from 0 (minimal pain) to 10(maximum pain) after the application of Platelet rich fibrin and hyaluronic acid and gel foam as a palatal dressing after harvesting a free gingival graft from the palate (donor site)

    one month

Secondary Outcomes (1)

  • assessment of healing using the healing index scale by Landry et al1984

    one month

Study Arms (3)

PRF

ACTIVE COMPARATOR

PRF membrane is placed in the area where the free gingival graft was taken from the palate

Other: Platelet rich fibrin

hyaluronic acid

ACTIVE COMPARATOR

hyaluronic acid gel is placed in the area where the free gingival graft was taken from the palate and the patient is instructed to place the gel 3 times per day

Drug: hyaluronic acid (Gengiegel 0.2% oral gel )

Gel foam

ACTIVE COMPARATOR

Gel foam is placed in the area where the free gingival graft was taken from the palate

Other: Gel foam

Interventions

coverage of the free gingival graft area in the palate

Also known as: Platelet rich fibrin (PRF)
hyaluronic acid

coverage of the free gingival graft area in the palate

Also known as: PRF
PRF

coverage of the free gingival graft area in the palate

Gel foam

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients who are indicated for soft tissue augmentation with free gingival graft for mucogingival surgery or for implant therapy
  • Good patient compliance with the plaque control instructions following initial therapy.

You may not qualify if:

  • Presence of systemic diseases which could influence the outcome of the therapy
  • Smoker patients.
  • Pregnant females
  • Vulnerable group of patients (prisoners ,handicapped, decisionally impaired individuals)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry ,Ain Shams University

Cairo, 1113311, Egypt

Location

MeSH Terms

Interventions

Hyaluronic AcidGelsVaginal Creams, Foams, and Jellies

Intervention Hierarchy (Ancestors)

GlycosaminoglycansPolysaccharidesCarbohydratesColloidsComplex MixturesDosage FormsPharmaceutical PreparationsFeminine Hygiene ProductsEquipment and Supplies

Study Officials

  • Ahmed abdel aziz hassan, Associate Professor

    faculty of dentistry ain shams university

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 3 groups each receiving a different type of intervention
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator(teaching assistant)

Study Record Dates

First Submitted

May 9, 2020

First Posted

May 15, 2020

Study Start

February 1, 2019

Primary Completion

December 1, 2019

Study Completion

February 1, 2020

Last Updated

May 15, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will share

sharing of the study methodology and the clinical results

Shared Documents
STUDY PROTOCOL, CSR
Time Frame
the data will be available for a year from it's submission date

Locations